Schrand, Brett
Clark, Emily
Levay, Agata
Capote, Ailem Rabasa
Martinez, Olivier
Brenneman, Randall
Castro, Iris
Gilboa, Eli
Article History
Received: 5 February 2018
Accepted: 11 July 2018
First Online: 22 August 2018
Change Date: 5 September 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
Change Date: 22 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-25400-1
Competing interests
: E.G. is a founder and equity holder of Sebastian Biopharma that holds the intellectual rights for the hapten-mediated antibody recruitment approach. The remaining authors declare no competing interests.